Revenue: The sum of all revenue fields included for a company's operating activities.
Altimmune, Inc. (ALT) had Revenue of $0.01M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
|
Revenue |
$0.01M |
$-22.84M |
|
-- |
|
$0.01M |
|
$24.77M |
|
$-24.77M |
|
$1.92M |
|
$-22.84M |
|
$-22.84M |
|
$-22.84M |
|
$-22.84M |
|
$-22.84M |
|
$-22.84M |
|
$-24.77M |
|
$-25.71M |
|
71.08M |
|
71.08M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$145.76M |
|
$0.45M |
|
$2.10M |
|
$147.86M |
|
$8.64M |
|
-- |
|
$5.85M |
|
$14.49M |
|
$133.38M |
|
$133.38M |
|
$133.38M |
|
71.12M |
|
| Cash Flow Statement Financials | |
$-61.58M |
|
$-42.02M |
|
$-0.04M |
|
$135.16M |
|
$31.52M |
|
$-103.64M |
|
$11.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-495340.00% |
|
-495340.00% |
|
-- |
|
-456900.00% |
|
-456900.00% |
|
$-61.58M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
-- |
|
-17.13% |
|
-17.13% |
|
-15.45% |
|
-17.13% |
|
$1.88 |
|
$-0.87 |
|
$-0.87 |
|